Halozyme Therapeutics | HALO - EPS Earnings Per Share



Halozyme Therapeutics reported $1.54 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 1.59 1.27 Nov/10 2025
FY2025Q2 Jun/2025 1.54 1.21 0.91 Aug/05 2025
FY2025Q1 Mar/2025 1.11 0.96 0.79 May/06 2025
FY2024Q4 Dec/2024 1.26 1.15 0.82 Feb/18 2025
FY2024Q3 Sep/2024 1.27 0.96 0.75 Oct/31 2024
FY2024Q2 Jun/2024 0.91 0.76 0.74 Aug/06 2024
FY2024Q1 Mar/2024 0.79 0.69 0.47 May/07 2024
FY2023Q4 Dec/2023 0.82 0.80 0.48 Feb/20 2024
FY2023Q3 Sep/2023 0.75 0.70 0.74 Nov/06 2023
FY2023Q2 Jun/2023 0.74 0.62 0.53 Aug/08 2023
FY2023Q1 Mar/2023 0.47 0.47 0.47 May/09 2023
FY2022Q4 Dec/2022 0.48 0.47 0.42 Feb/21 2023


Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Agios Pharmaceuticals USD -1.93 0.38 Jun/2025
Alnylam Pharmaceuticals USD 0.32 0.33 Jun/2025
Amarin USD -0.03 0.01 Jun/2025
Amgen USD 6.02 1.12 Jun/2025
Baxter International USD 0.59 0.04 Jun/2025
Cytokinetics USD -1.12 0.24 Jun/2025
DBV Technologies EUR -1.55 0.25 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
Halozyme Therapeutics USD 1.54 0.43 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
MannKind USD 0.05 0.01 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
United Therapeutics USD 6.41 0.22 Jun/2025